![]() |
市场调查报告书
商品编码
1957218
单极电外科器材市场-全球产业规模、份额、趋势、机会、预测:按类型、应用、最终用途、地区和竞争对手划分,2021-2031年Monopolar Electrosurgery Instrument Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Application, By End Use, By Region & Competition, 2021-2031F |
||||||
全球单极电外科器械市场预计将从 2025 年的 38.9 亿美元成长到 2031 年的 50.1 亿美元,复合年增长率为 4.31%。
该市场以使用单一活性电极向特定组织输送电流的设备为特征,需要患者侧的回流电极来完成迴路,以实现有效的切开和凝血。推动市场成长的主要因素包括:需要手术介入的慢性疾病数量不断增加、全球人口老化以及全球手术数量的持续成长。这些因素使得急诊护理领域对可靠设备的需求日益迫切,而强劲的经济环境也支撑着这项需求。根据欧洲医疗技术协会(MedTech Europe)预测,到2024年,欧洲医疗技术市场规模将达到约1,700亿欧元。
| 市场概览 | |
|---|---|
| 预测期 | 2027-2031 |
| 市场规模:2025年 | 38.9亿美元 |
| 市场规模:2031年 | 50.1亿美元 |
| 复合年增长率:2026-2031年 | 4.31% |
| 成长最快的细分市场 | 医院 |
| 最大的市场 | 北美洲 |
儘管市场成长势头强劲,但由于医疗设备核准监管条件严格,市场仍面临许多障碍。製造商必须应对复杂的合规要求,例如欧盟医疗设备法规 (MDR) 的规定,这会显着增加研发成本并延缓产品上市。这些监管负担对中小企业构成准入壁垒,并可能透过减缓新技术应用而阻碍市场整体扩张步伐。
随着微创手术需求的不断增长,单极电外科器械的全球市场需求也日益旺盛。这些高度依赖电外科精准操作以减轻患者身体负担的技术正被广泛应用。单极器械,包括主动电极和腹腔镜钩,对于此类手术至关重要,因为它们能够在有限的解剖空间内提供必要的切割和凝血功能。采用专用电外科末端执行器的机器人平台的日益普及进一步强化了这一趋势。特别是,直觉外科公司(Intuitive Surgical)在2025年1月发布的报告显示,2024年全球达文西手术数量将增加约17%,证实了手术数量的成长正在推动器械的使用。
同时,慢性疾病(尤其是癌症)发生率的不断上升,正成为市场成长的主要驱动力,因为这些疾病需要频繁的手术介入。电外科手术仍然是肿瘤切除和组织处理的标准治疗方法,确保了在急诊环境中对可靠的单极电外科设备持续的需求。美国癌症协会 (ACS) 截至 2024 年 1 月的预测显示,2024 年美国新增癌症病例将超过 200 万例,这将导致对外科治疗的需求显着增加。製造商正在部署大规模商业生产以满足这一需求。Medtronic于 2024 年 5 月发布的一份报告显示,其医疗外科产品组合创造了 84 亿美元的收入,这反映了这一关键外科基础设施的巨大规模。
医疗设备认证的严格法规环境对全球单极电外科器械市场的成长构成重大阻碍。欧盟医疗设备管理局 (FDA) 标准等框架,要求提供比以往任何时候都更全面的临床证据和更严格的上市后监管。这种日益严格的监管迫使製造商将更多的资金和时间投入到合规性方面,而非研发。对于需要频繁更新电极形状和发生器相容性的电外科器械而言,冗长的核准流程会延缓产品开发,并限制创新技术的市场准入。
这项监管瓶颈正对企业的策略性上市决策产生重大影响。 MedTech Europe 2024年的数据显示,选择欧盟作为其新医疗设备首发主要市场的主要製造商数量较MDR实施前下降了33%。这项数据清楚地表明,监管的复杂性正迫使企业放弃一些关键市场。因此,先进单极电外科器械的普及速度正在放缓,直接降低了收入潜力,并阻碍了全球市场的整体成长。
旨在提升手术室职业安全的严格法律法规正推动将排烟装置整合到牙科手机中,这已成为一项重要的市场趋势。监管机构和州立法机构日益认识到手术烟雾的健康风险,并强制要求医疗机构将标准笔式手柄更换为内置吸力功能的活性电极手柄。这种监管压力迫使医院采用符合规定的设备,以避免处罚并保护员工。根据《ASC Focus》杂誌2024年5月刊报道,明尼苏达州、维吉尼亚和西维吉尼亚于2024年颁布了手术烟雾排放法,使美国拥有此类法律的州总数达到18个,进一步推动了对具有排放功能的设备的需求。
同时,门诊和日间手术中心采购量的增加正在从根本上改变买方结构,将需求从传统的急诊医院转移出去。这些机构优先考虑营运效率和高患者处理能力,因此需要经济高效且可靠的单极器械,用于常规手术。手术量转移到低成本环境的转移正在为製造商建立强大的销售管道。这项变更在领先的门诊机构营运商的财务表现中显而易见;例如,根据 Becker's ASC Review 2024 年 10 月的报告,United Surgical Partners International 第三季度收入增长了 21%,这反映了门诊手术量激增,从而推动了器械消耗。
The Global Monopolar Electrosurgery Instrument Market is projected to expand from a valuation of USD 3.89 Billion in 2025 to USD 5.01 Billion by 2031, reflecting a compound annual growth rate of 4.31%. This market is characterized by the use of devices that utilize a single active electrode to deliver electrical current to specific tissues, necessitating a patient return electrode to complete the circuit for effective cutting and coagulation. Growth is primarily driven by the increasing prevalence of chronic diseases that require surgical intervention, a globally aging population, and a steady rise in the volume of surgical procedures worldwide. These factors create a crucial need for reliable instrumentation in acute care, a demand supported by a robust economic environment where the European medical technology market was valued at roughly €170 billion in 2024, according to MedTech Europe.
| Market Overview | |
|---|---|
| Forecast Period | 2027-2031 |
| Market Size 2025 | USD 3.89 Billion |
| Market Size 2031 | USD 5.01 Billion |
| CAGR 2026-2031 | 4.31% |
| Fastest Growing Segment | Hospitals |
| Largest Market | North America |
Despite this positive growth trajectory, the market encounters significant hurdles due to the rigorous regulatory landscape governing medical device approvals. Manufacturers are required to navigate complex compliance mandates, such as the European Union Medical Device Regulation (MDR), which can substantially inflate development costs and postpone product launches. These regulatory burdens frequently establish barriers to entry for smaller companies and decelerate the introduction of new technologies, potentially hindering the overall pace of market expansion.
Market Driver
The escalating demand for minimally invasive surgical procedures serves as a significant propellant for the Global Monopolar Electrosurgery Instrument Market, as these techniques depend heavily on electrosurgical precision to reduce patient trauma. Monopolar instruments, including active electrodes and laparoscopic hooks, are vital for these operations, offering necessary cutting and coagulation functions within confined anatomical spaces. This trend is reinforced by the growing adoption of robotic platforms utilizing specialized electrosurgical end-effectors; notably, Intuitive Surgical reported in January 2025 that worldwide da Vinci procedures increased by approximately 17% in 2024, underscoring the rising surgical volume driving instrument usage.
Concurrently, the increasing prevalence of chronic diseases, especially cancer, acts as a primary driver for market growth by requiring frequent surgical interventions. Electrosurgery continues to be a standard of care for tumor resection and tissue management, guaranteeing sustained demand for reliable monopolar devices in acute care environments. According to the American Cancer Society's January 2024 figures, over 2 million new cancer cases were projected to be diagnosed in the United States in 2024, creating a substantial requirement for surgical treatment. Manufacturers are meeting this need with significant commercial output, as evidenced by Medtronic's May 2024 report showing its Medical Surgical Portfolio generated $8.4 billion in revenue, reflecting the massive scale of this critical surgical infrastructure.
Market Challenge
The stringent regulatory environment surrounding medical device approval presents a major obstacle to the growth of the Global Monopolar Electrosurgery Instrument Market. Frameworks such as the European Union Medical Device Regulation (MDR) and evolving FDA standards now require more comprehensive clinical evidence and rigorous post-market surveillance than in the past. This heightened scrutiny compels manufacturers to divert substantial capital and time toward compliance efforts rather than research and development. For electrosurgical instruments, which frequently necessitate updates to electrode geometry and generator compatibility, these prolonged approval timelines delay product commercialization and limit the entry of innovative technologies.
This regulatory bottleneck significantly impacts strategic launch decisions, as demonstrated by MedTech Europe data from 2024 indicating a 33% decline in large manufacturers selecting the European Union as their primary geography for first launching new medical devices compared to the pre-MDR era. This statistic reveals a distinct shift where companies are deprioritizing major markets due to regulatory complexities. Consequently, the availability of advanced monopolar electrosurgery tools is retarded, which directly diminishes revenue potential and suppresses the overall expansion rate of the global market.
Market Trends
The integration of smoke evacuation mechanisms into handpieces is gaining momentum as a critical market trend, largely driven by strict legislative mandates designed to enhance occupational safety in operating rooms. Regulatory bodies and state legislatures are increasingly acknowledging the health risks associated with surgical smoke plumes, forcing facilities to switch from standard pencils to active electrodes equipped with built-in suction capabilities. This regulatory pressure compels hospitals to acquire compliant instrumentation to avoid penalties and protect staff; according to ASC Focus Magazine in May 2024, Minnesota, Virginia, and West Virginia enacted surgical smoke evacuation laws in 2024, raising the total number of U.S. states with such mandates to 18 and fueling demand for evacuation-enabled devices.
Simultaneously, the increased procurement by ambulatory and outpatient surgical centers is fundamentally altering the buyer landscape by shifting volume away from traditional acute care hospitals. These facilities emphasize operational efficiency and high patient throughput, requiring cost-effective and reliable monopolar instruments tailored for routine procedures. The migration of surgical volume to these lower-cost settings is establishing a robust sales channel for manufacturers, a shift highlighted by the financial results of leading outpatient operators; for instance, a report by Becker's ASC Review in October 2024 noted that United Surgical Partners International saw a 21% increase in third-quarter revenue, underscoring the surging procedural activity in outpatient settings that drives instrument consumption.
Report Scope
In this report, the Global Monopolar Electrosurgery Instrument Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Monopolar Electrosurgery Instrument Market.
Global Monopolar Electrosurgery Instrument Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: